Trial Profile
The Physiological Effects of GLP-1 on Haemodynamics During Exercise in Patients With Ischaemic Heart Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms LIONESS
- 19 May 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
- 29 Jan 2015 Planned End Date changed from 1 Feb 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
- 29 Jan 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.